Since the beginning of the pandemic, efforts have been focused on developing a vaccine capable of providing immunity against SARS-CoV-2. With multiple vaccine candidates now demonstrating exceptionally high efficacy against…
Tag: patent protection
TRIPS: A Barrier to Covid-19 Vaccine Access?
With international efforts to administer the Covid-19 vaccinations underway, a glaring disparity in the vaccine distribution has emerged. High-income countries, composing about 16% of the world’s population, have purchased approximately…
Bringing Biologics in from the Cold: Does Canada’s IP Regime Need a Booster?
As ratification stutters for the Comprehensive Economic and Trade Agreement (CETA), the much-maligned free-trade deal between Canada and the European Union, debate continues as to whether the Canadian intellectual property…
The View Ahead for Software Patent Applications: USPTO Releases Update to Guidance on Patent Subject Matter Eligibility
This article is cross-posted with permission from Bereskin & Parr. The United States Patent and Trademarks Office (USPTO) has released an updated set of Eligibility Examination Guidelines to provide guidance…
in Feature Post, IP, IP Course Topic, IP Intensive, Patents, Pharmaceutical Drugs, Regulatory Policy1by Editor
622
CETA: An Opportunity to Fix Canada's Broken Pharmaceutical Patent Linkage System
This is an excerpt from a paper by Adam Falconi, the recipient of the 2015 Barry D. Tomo Memorial Prize for best research paper on a subject related to industrial…